Hepatocellular carcinoma (HCC) poses a significant global health challenge, and liver
transplantation (LT) remains the best curative option. Living donor liver transplantation …

Background Very few centers in Pakistan have all established treatments for hepatocellular
carcinoma (HCC) available under one roof. With a dedicated hepato-pancreato-biliary …

Background Living donor liver transplantation (LDLT) is an acceptable treatment option for
hepatocellular carcinoma (HCC). Traditional transplant criteria aim at best utilization of …

Living transplantation is an established treatment for patients with hepatocellular carcinoma
(HCC) and cirrhosis [1]. Liver transplantation for intra hepatic cholangiocarcinoma (i-CC) or …

Objective: Despite moderate sensitivity, alpha fetoprotein (AFP) is widely used in screening
and prognostication for hepatocellular carcinoma (HCC). The objective of the current study …

Background: In deceased donor liver transplantation (DDLT), transplant eligibility for T3–T4
HCC requires successful downstaging (DS). Living donor liver transplantation (LDLT) can …

Purpose The role of preoperative locoregional therapy (LRT) for hepatocellular carcinoma
(HCC) before liver transplantation (LT) remains unclear. Moreover, LRT in the setting of …

ABSTRACT Background and Aim: Hepatocellular carcinoma (HCC) is the primary liver
cancer around the world, and it has now become the third leading cause of cancer-related …

Abstract In the United Arab Emirates (UAE), the burden of hepatocellular carcinoma is low
but rising gradually. While the total burden remains small (about 220 new cases annually) …

Background In the context of liver transplantation for hepatocellular carcinoma (HCC),
traditional transplant criteria appear restrictive. The objective of the current study was to …